成人呼吸衰竭无创通气下体外膜氧合的系统评价
该系统评价检索PubMed、Web of Science和Scopus,纳入57项报告成人呼吸衰竭清醒ECMO结局的研究(28项病例报告),共467例清醒ECMO患者。主要终点为清醒ECMO失败率(需插管):急性呼吸窘迫综合征亚组汇总失败率为39.3%(95%CI 24.0-54.7%),桥接肺移植患者为23.4%(95%CI 13.3-33.5%)。最长随访死亡率为121/439(汇总估计28%,95%CI 22.3-33.6%);清醒ECMO策略失败者死亡率为43/74(汇总估计57.2%,95%CI 40.2-74.3%)。报告2例导管自行拔除。作者认为清醒ECMO在部分选择患者中可行,但对结局的影响尚待证实。
要点
- 清醒ECMO失败(需插管)后死亡率高:43/74,汇总估计57.2%(95%CI 40.2-74.3%)。
- 急性呼吸窘迫综合征患者清醒ECMO失败率汇总估计39.3%(95%CI 24.0-54.7%)。
- 桥接肺移植患者清醒ECMO失败率汇总估计23.4%(95%CI 13.3-33.5%)。
- 最长随访死亡率汇总估计28%(95%CI 22.3-33.6%,121/439)。
- 报告2例导管自行拔除,清醒ECMO期间需关注导管安全。
适用人群与场景
- 成人呼吸衰竭接受清醒ECMO(无创通气)的患者;排除心血管衰竭、心脏骤停或围手术期支持的研究,以及儿科患者。
红旗征与不能漏的情况
- 清醒ECMO策略失败(需插管)者死亡率汇总估计57.2%(95%CI 40.2-74.3%,43/74)。
- 报告2例导管自行拔除。
研究设计与关键结果
- 系统评价纳入57项研究(28项病例报告),共467例清醒ECMO患者。
- 主要终点清醒ECMO失败率(需插管):急性呼吸窘迫综合征亚组汇总估计39.3%(95%CI 24.0-54.7%),桥接肺移植亚组23.4%(95%CI 13.3-33.5%)。
- 最长随访死亡率:121/439,汇总估计28%(95%CI 22.3-33.6%)。
- 清醒ECMO失败者死亡率:43/74,汇总估计57.2%(95%CI 40.2-74.3%)。
- 报告2例导管自行拔除。
证据类型、等级与局限
- 证据类型:系统评价(纳入57项研究,其中28项病例报告)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为清醒ECMO在部分选择患者中可行,但对结局的影响尚待证实。
- 作者指出清醒ECMO策略失败者死亡率接近60%。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for acute severe respiratory failure. Patients on ECMO are frequently maintained sedated and immobilized until weaning from ECMO, first, and then from mechanical ventilation. Avoidance of sedation and invasive ventilation during ECMO may have potential advantages. We performed a systematic literature review to assess efficacy and safety of awake ECMO without invasive ventilation in patients with respiratory failure.
DATA SOURCES: PubMed, Web of Science, and Scopus were searched for studies reporting outcome of awake ECMO for adult patients with respiratory failure.
STUDY SELECTION: We included all studies reporting outcome of awake ECMO in patients with respiratory failure. Studies on ECMO for cardiovascular failure, cardiac arrest, or perioperative support and studies on pediatric patients were excluded. Two investigators independently screened and selected studies for inclusion.
DATA EXTRACTION: Two investigators abstracted data on study characteristics, rate of awake ECMO failure, and mortality. Primary outcome was rate of awake ECMO failure (need for intubation). Pooled estimates with corresponding 95% CIs were calculated. Subgroup analyses by setting were performed.
DATA SYNTHESIS: A total of 57 studies (28 case reports) included data from 467 awake ECMO patients. The subgroup of patients with acute respiratory distress syndrome showed a pooled estimate for awake ECMO failure of 39.3% (95% CI, 24.0-54.7%), while in patients bridged to lung transplantation, pooled estimate was 23.4% (95% CI, 13.3-33.5%). Longest follow-up mortality was 121 of 439 (pooled estimate, 28%; 95% CI, 22.3-33.6%). Mortality in patients who failed awake ECMO strategy was 43 of 74 (pooled estimate, 57.2%; 95% CI, 40.2-74.3%). Two cases of cannula self-removal were reported.
CONCLUSIONS: Awake ECMO is feasible in selected patients, although the effect on outcome remains to be demonstrated. Mortality is almost 60% in patients who failed awake ECMO strategy.
参考来源
- Belletti A, Sofia R, Cicero P, et al. Extracorporeal Membrane Oxygenation Without Invasive Ventilation for Respiratory Failure in Adults: A Systematic Review. Crit Care Med. 2023. PMID: 37971332. doi:10.1097/CCM.0000000000006027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。